gene

G3BP1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about G3BP1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1218Connections
4Hypotheses
10Analyses
50Outgoing
50Incoming
13Experiments
7Debates

Summary

G3BP1 is a gene implicated in neurodegeneration research. Key relationships include: interacts with, activates, regulates. Associated with AD, ALI, ALS. Connected to 448 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolG3BP1
Full NameRas-GTPase-Activating Protein-Binding Protein 1
Chromosome5q33.1
Protein TypeSignaling Protein
Target ClassSignaling Protein
FunctionSG Nucleation: G3BP1 acts as a scaffold for SG assembly, recruiting other SG components
Mechanism of ActionG3BP1 inhibitors would prevent stress granule assembly and stabilization by disrupting the interaction between G3BP1 and its binding partners, potentially reducing pathological aggregation of TDP-43 and FUS proteins. This mechanism could alleviate neurodegeneration in conditions characterized by aberrant stress granule formation and RNA metabolism dysfunction.
Primary ExpressionUbiquitous, high in brain (neurons, glia)
DruggabilityMedium (0.47)
Clinical StagePhase II
Molecular Weight~52 kDa
PathwaysApoptosis, Autophagy, Er Stress, Immune Response, Mtor
UniProt IDA0A7I2V3C4
NCBI Gene ID9973
Ensembl IDENSG00000130830
GeneCardsG3BP1
Human Protein AtlasG3BP1
Associated DiseasesAD, ALI, Als, Alzheimer, AMI
Known Drugs/Compoundsaxonal mRNA, EGCG, Intracellular Free Rna, rapamycin, trehalose
InteractionsABCD3, ACTB, Actin, Akt, AKT, ALS
SciDEX TargetView Target Profile (7 clinical trials)
SciDEX HypothesesPhase-Separated Organelle Targeting
Stress Granule Phase Separation Modulators
RNA Granule Nucleation Site Modulation (+1 more)
KG Connections1218 knowledge graph edges
DatabasesGeneCardsHPASTRING
🧬 3D Structure Comparison — G3BP1 Experimental (PDB) vs Predicted (AlphaFold) — click to expand

📄 Experimental Structure

4FCJ — X-ray / Cryo-EM

🔮 AI Predicted Structure

A0A7I2V3C4 — AlphaFold

Left: Experimental structure from RCSB PDB | Right: AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (2)

Knowledge base pages for this entity

Canonical Page

G3BP1

gene · 1167 words

G3BP1 Protein — Ras-GTPase-Activating Protein-Binding Protein 1

protein · 792 words

Pathway Diagram

graph TD
    G3BP1["G3BP1"] -->|"associated"| neurodegeneration["neurodegeneration"]
    G3BP1["G3BP1"] -->|"co discussed"| SRPK1["SRPK1"]
    TGM2["TGM2"] -->|"co discussed"| G3BP1["G3BP1"]
    PRMT1["PRMT1"] -->|"co discussed"| G3BP1["G3BP1"]
    PARP1["PARP1"] -->|"co discussed"| G3BP1["G3BP1"]
    HSPA1A["HSPA1A"] -->|"co discussed"| G3BP1["G3BP1"]
    style G3BP1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (783)

TargetRelationTypeStr
Stress Granulesassociated_withprocess0.95
Liquid-Liquid Phase Separationmediatesprocess0.95
STRESS GRANULE ASSEMBLYregulatesentity0.95
Stress Granule Formationmediatesprocess0.95
Stress Granule Disassemblymediatesprocess0.95

Incoming (435)

SourceRelationTypeStr
Ubiquitinationmodulatesprocess0.95
UBIQUITINATIONmodulatesentity0.95
Nsp3bindsprotein0.95
TRIM21phosphorylatesprotein0.95
hiPSC-derived lung organoidexpressed_incell_type0.95

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Phase-Separated Organelle Targeting 0.729 neurodegeneration Microglia-astrocyte crosstalk amplificat
Stress Granule Phase Separation Modulators 0.720 neurodegeneration RNA binding protein dysregulation across
RNA Granule Nucleation Site Modulation 0.662 neurodegeneration TDP-43 phase separation therapeutics for
Liquid-Liquid Phase Separation Modifier Therapy 0.656 neurodegeneration Protein aggregation cross-seeding across

Mentioning Analyses (10)

Scientific analyses that reference this entity

What determines the spatial organization of autophagy receptors at stress granul

neurodegeneration | 2026-04-08 | 0 hypotheses

What determines the specificity of RNA-protein interactions that drive distinct

neurodegeneration | 2026-04-07 | 0 hypotheses

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

neurodegeneration | 2026-04-07 | 0 hypotheses

How do pathological stress granules transition from reversible to persistent in

neurodegeneration | 2026-04-06 | 0 hypotheses

How do pathological stress granules in neurodegeneration escape TRIM21/autophagy

neurodegeneration | 2026-04-06 | 0 hypotheses

Experiments (13)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
TRIM21-mediated K63-linked ubiquitination of G3BP1 exploratory 0.950 0.00 in vitro biochemical assays, c proposed N/A
G3BP1-mediated stress granule assembly via liquid-liquid phase separat exploratory 0.900 0.00 eukaryotic cells proposed N/A
G3BP1 intrinsically disordered region analysis and phosphorylation eff exploratory 0.850 0.00 in vitro protein analysis syst proposed N/A
G3BP1-binding factor cooperativity in stress granule network regulatio exploratory 0.800 0.00 cell culture systems with prot proposed N/A
Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FTD validation ALS 0.400 0.50 human proposed $2,730,000
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study clinical ALS 0.400 0.50 human proposed $6,550,000
Pre-Symptomatic Detection and Intervention Timing in Genetic Prion Dis validation ALS 0.400 0.50 human proposed $2,280,000
Stress Granule Dysfunction Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Experiment Validation: In vitro ThT Assay validation Alzheimer's Disease 0.400 0.50 cell_line proposed $160,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val validation Neurodegeneration 0.400 0.50 human proposed $3,000,000
Multiscale Computational Modeling of Protein Aggregation Kinetics validation Parkinson's Disease 0.400 0.50 human proposed $2,280,000
Protein Aggregation Kinetic Validation Results validation Neurodegeneration 0.400 0.50 in_silico proposed $120,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3B [PMID:36692217] Yang C, Wang Z, Kang Y, Yi Q, Wang T, Ba Autophagy 2023 3
G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Gran [PMID:32302571] Yang P, Mathieu C, Kolaitis RM, Zhang P, Cell 2020 3
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic t [PMID:32048886] Yao RQ, Ren C, Xia ZF, Yao YM Autophagy 2021 2
Hypoxia-driven phase separation of the PABP1/eIF4B complex forms stress granules [PMID:41780839] Lin Z, Gao Y, Zhang Q, Yang S, Chen Y, D Cancer Lett 2026 1
LINC00599 Promotes Pulmonary Hypertension via Liquid-Liquid Phase Separation Wit [PMID:40693377] Wang Y, Yin L, Zheng S, Liu A, Liu C, Ba Hypertension 2025 1
The important role of stress granules in prostate cancer development, progressio [PMID:40972860] Xu Z, You H, Gu J, Jiang J, Yan Z, Jin X Gene 2025 1
Membrane Atg8ylation, stress granule formation, and MTOR regulation during lysos [PMID:36394332] Jia J, Wang F, Bhujabal Z, Peters R, Mud Autophagy 2023 1
Role of stress granules in modulating senescence and promoting cancer progressio [PMID:34460104] Chatterjee D, Chakrabarti O Int J Cancer 2022 1
Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specifi [PMID:34739333] Gwon Y, Maxwell BA, Kolaitis RM, Zhang P Science 2021 1
STING is the scaffold protein for stress granule pre-condensation at the ER. [PMID:41917183] Eom E, Kim J, Kim J, Kang SJ Cell death and differentiation 2026 0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077] ["Desai M", "Gulati K", "Agrawal M", "Gh Neural regeneration research 2026 0
WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity [PMID:41915747] Li Z, Wang Y, Chen Z, Liu R, Lai ZH, Li Proceedings of the National Ac 2026 0
NUP93 facilitates the nuclear import of SOX2 to activate G3BP1 transcription and [PMID:41896201] Sun H, Yang C, Du J, Xu C, Chen Y, Chen Cell death & disease 2026 0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769] Sharma S, Vandenakker A, Cortés-Pérez C, Translational neurodegeneratio 2026 0
Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by sup [PMID:41920932] Mulloy RP, Evseev D, Sharlin N, Bui-Mari PLoS biology 2026 0
PRRC2A, PRRC2B and PRRC2C are Stress Granule Proteins that Promote Translation T [PMID:41808986] ["Huang J", "Kadijk E", "Schreiber K", " bioRxiv : the preprint server 2026 0
Rainbow trout (Oncorhynchus mykiss) G3BP1 function as an antiviral molecule agai [PMID:41831384] ["Zhao J", "Shao Y", "Liu W", "Lu T", "X Fish & shellfish immunology 2026 0
Stress granules at the crossroads of retroviral replication and antiviral immuni [PMID:41931190] Akbarin MM, Farjami Z, Álvarez HR Mol Biol Rep 2026 0
Tetramethylthiuram disulfide induces stress granules and DNA damage through oxid [PMID:41822241] ["Lin M", "Lee S", "Gwak J", "Cha J", "H Animal cells and systems 2026 0
Androgen receptor localisation and protein interactions provide insight into ste [PMID:41844688] ["Bleach R", "Bozkurt E", "Xin J", "Shee NPJ breast cancer 2026 0

Debates (7)

Multi-agent debates referencing this entity

Protein aggregation cross-seeding across neurodegenerative diseases?

closed · Rounds: 4 · Score: 0.70 · 2026-04-12

RNA binding protein dysregulation across ALS FTD and AD

closed · Rounds: 4 · Score: 0.72 · 2026-04-12

TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small

closed · Rounds: 6 · Score: 0.84 · 2026-04-12

TDP-43 phase separation therapeutics for ALS-FTD

closed · Rounds: 4 · Score: 0.95 · 2026-04-11

Microglia activate astrocytes via IL-1alpha/TNF/C1q, and reactive astrocytes fee

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

Analysis question not specified

closed · Rounds: 4 · Score: 0.53 · 2026-04-06

RNA binding protein dysregulation across ALS FTD and AD

closed · Rounds: 4 · Score: 0.88 · 2026-04-06